Hearing and Neurodevelopmental Outcomes of Young Infants with Parechovirus-A and Enterovirus Meningitis: Cohort Study in Singapore Children and Literature Review

Abstract

Parechovirus-A (PeV-A) and Enterovirus (EV) commonly cause childhood aseptic meningitis. Bacterial meningitis in children has been associated with devastating long-term sequelae. However, developmental outcomes are unclear in Parechovirus meningitis. This study aims to review the clinical findings and developmental outcomes of infants with PeV-A and EV meningitis. We performed a retrospective study of infants aged 90 days or younger being admitted to our hospital with PeV-A meningitis between November 2015 and July 2017, with positive cerebrospinal fluid (CSF) PeV-A PCR and negative blood and CSF bacterial cultures. Hearing and neurodevelopmental outcomes were compared with a previous cohort of infants aged 90 days or younger with EV meningitis admitted from January 2015 to December 2015. A total of 161 infants were included in our study, of which 68 infants (42.2%) had PeV-A meningitis and 93 infants (57.8%) had EV meningitis. We assessed their developmental outcome at 6 months, 1 year, and 2 years post-meningitis. At 2 years post-meningitis, three infants with PeV-A meningitis had developmental delay (5.5%), whereas none with EV meningitis had developmental delay. One patient had speech delay and autism spectrum disorder, while two had mild speech delay. When compared with our cohort of EV meningitis ≤90 days old, children with PeV-A meningitis ≤90 days old were more likely to have developmental delay 2 years post-meningitis (odds ratio 2.4, 95% confidence interval 2.0–3.0, p = 0.043). None of the patients with PeV-A or EV meningitis had sensorineural hearing loss or neurological sequelae, such as cortical blindness, oropharyngeal dysphagia, hydrocephalus, epilepsy, or cerebral palsy. Infants with PeV-A meningitis had a significant risk of developmental delay 2 years post-meningitis compared with those with EV meningitis. It is important to follow-up the developmental milestones of infants diagnosed with PeV-A meningitis for at least 2 years; and when they develop developmental delay, to ensure that they receive appropriate intervention.

Keywords

meningitis - neurodevelopmental outcome - infants - Parechovirus - Enterovirus

Publikationsverlauf

Eingereicht: 03. Juni 2020

Angenommen: 27. Juli 2020

Artikel online veröffentlicht:
16. September 2020

• References

• 1 Tan NWH, Lee EY, Khoo GMC, Tee NW, Krishnamoorthy S, Choong CT. Cerebrospinal fluid white cell count: discriminatory or otherwise for enteroviral meningitis in infants and young children?. J Neurovirol 2016; 22 (02) 213-217
• 2 Kadambari S, Okike I, Ribeiro S. et al. Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. J Infect 2014; 69 (04) 326-332
• 3 Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human Parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J 2011; 30 (03) 238-242
• 4 Kadambari S, Braccio S, Ribeiro S. et al. Enterovirus and Parechovirus meningitis in infants younger than 90 days old in the UK and Republic of Ireland: a British Paediatric Surveillance Unit study. Arch Dis Child 2019; 104 (06) 552-557
• 5 Harvala H, Simmonds P. Human Parechoviruses: biology, epidemiology and clinical significance. J Clin Virol 2009; 45 (01) 1-9
• 6 Vergnano S, Kadambari S, Whalley K. et al. Characteristics and outcomes of human Parechovirus infection in infants (2008-2012). Eur J Pediatr 2015; 174 (07) 919-924
• 7 Tang JW, Holmes CW, Elsanousi FA. et al. Cluster of human parechovirus infections as the predominant cause of sepsis in neonates and infants,. Leicester, United Kingdom, 8 May to 2 August 2016.: Euro Surveill; 2016. 21. (34): 30326
• 8 Hudson JA, Broad J, Martin NG. et al. Outcomes beyond hospital discharge in infants and children with viral meningitis: a systematic review. Rev Med Virol 2020; 30 (02) e2083
• 9 Rotbart HA. Diagnosis of enteroviral meningitis with the polymerase chain reaction. J Pediatr 1990; 117 (1 Pt 1): 85-89
• 10 Corless CE, Guiver M, Borrow R. et al. Development and evaluation of a ‘real-time’ RT-PCR for the detection of Enterovirus and Parechovirus RNA in CSF and throat swab samples. J Med Virol 2002; 67 (04) 555-562
• 11 Verstrepen WA, Kuhn S, Kockx MM, Van De Vyvere ME, Mertens AH. Rapid detection of Enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol 2001; 39 (11) 4093-4096
• 12 Monpoeho S, Coste-Burel M, Costa-Mattioli M. et al. Application of a real-time polymerase chain reaction with internal positive control for detection and quantification of Enterovirus in cerebrospinal fluid. Eur J Clin Microbiol Infect Dis 2002; 21 (07) 532-536
• 13 Verstrepen WA, Bruynseels P, Mertens AH. Evaluation of a rapid real-time RT-PCR assay for detection of Enterovirus RNA in cerebrospinal fluid specimens. J Clin Virol 2002; 25 (Suppl. 01) S39-S43
• 14 Selvaraju SB, Nix WA, Oberste MS, Selvarangan R. Optimization of a combined human Parechovirus-Enterovirus real-time reverse transcription-PCR assay and evaluation of a new Parechovirus 3-specific assay for cerebrospinal fluid specimen testing. J Clin Microbiol 2013; 51 (02) 452-458
• 15 Ferreras Antolín L, Kadambari S, Braccio S. et al. Parechovirus Surveillance Network. Increased detection of human Parechovirus infection in infants in England during 2016: epidemiology and clinical characteristics. Arch Dis Child 2018; 103 (11) 1061-1066
• 16 Biaukula VL, Tikoduadua L, Azzopardi K. et al. Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae. Int J Infect Dis 2012; 16 (04) e289-e295
• 17 Joseph L, May M, Thomas M. et al. Human Parechovirus 3 in infants: expanding our knowledge of adverse outcomes. Pediatr Infect Dis J 2019; 38 (01) 1-5
• 18 Chang LY, Huang LM, Gau SS. et al. Neurodevelopment and cognition in children after Enterovirus 71 infection. N Engl J Med 2007; 356 (12) 1226-1234
• 19 Baker RC, Kummer AW, Schultz JR, Ho M, Gonzalez del Rey J. Neurodevelopmental outcome of infants with viral meningitis in the first three months of life. Clin Pediatr (Phila) 1996; 35 (06) 295-301
• 20 Gau SS, Chang LY, Huang LM, Fan TY, Wu YY, Lin TY. Attention-deficit/hyperactivity-related symptoms among children with Enterovirus 71 infection of the central nervous system. Pediatrics 2008; 122 (02) e452-e458
• 21 Choo YY, Agarwal P, How CH, Yeleswarapu SP. Developmental delay: identification and management at primary care level. Singapore Med J 2019; 60 (03) 119-123
• 22 Lian WB, Ho SKY, Choo SHT. et al. Children with developmental and behavioural concerns in Singapore. Singapore Med J 2012; 53 (07) 439-445
• 23 van Hinsbergh TMT, Elbers RG, van Furth MAM, Obihara CCC. Longitudinal association between human Parechovirus central nervous system infection and gross-motor neurodevelopment in young children. Pediatr Infect Dis J 2019; 38 (02) 110-114
• 24 Balasubramanian H, Wagh D, Rao S, Keil AD, McMichael J. Developmental outcomes in cerebrospinal fluid proven enteroviral meningitis in neonates > 32 weeks of gestation. J Paediatr Child Health 2016; 52 (03) 327-332
• 25 Bao X, Wong V. Brainstem auditory-evoked potential evaluation in children with meningitis. Pediatr Neurol 1998; 19 (02) 109-112
• 26 Wee LYJ, Tanugroho RR, Thoon KC. et al. A 15-year retrospective analysis of prognostic factors in childhood bacterial meningitis. Acta Paediatr 2016; 105 (01) e22-e29
• 27 Chandran A, Herbert H, Misurski D, Santosham M. Long-term sequelae of childhood bacterial meningitis: an underappreciated problem. Pediatr Infect Dis J 2011; 30 (01) 3-6
• 28 Christie D, Rashid H, El-Bashir H. et al. Impact of meningitis on intelligence and development: a systematic review and meta-analysis. PLoS One 2017; 12 (08) e0175024